Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kinga Piorecka"'
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 17, p 9264 (2021)
The development in the area of novel anticancer prodrugs (conjugates and complexes) has attracted growing attention from many research groups. The dangerous side effects of currently used anticancer drugs, including cisplatin and other platinum based
Externí odkaz:
https://doaj.org/article/82bbbb600c4c40c78b559ed0839efcee
Autor:
Kinga Piorecka, Anna Janaszewska, Marta Majkowska, Monika Marcinkowska, Jan Kurjata, Slawomir Kazmierski, Ewa Radzikowska-Cieciura, Bartlomiej Kost, Przemyslaw Sowinski, Barbara Klajnert-Maculewicz, Wlodzimierz A. Stanczyk
Publikováno v:
Materials, Vol 13, Iss 23, p 5512 (2020)
A novel strategy, recently developed by us, to use polyhedral oligomeric silsesquioxanes (POSS) as an anti-cancer drug carrier is presented. Anthracycline:POSS complexes were prepared by simple co-addition of doxorubicin (DOX) or daunorubicin (DAU) w
Externí odkaz:
https://doaj.org/article/c6cac99d423f4df68c438b022f730abb
Publikováno v:
Molecules, Vol 26, Iss 1, p 47 (2020)
Anthracyclines belong to the anticancer drugs that are widely used in chemotherapy. However, due to their systemic toxicity they also exert dangerous side effects associated mainly with cardiovascular risks. The pathway that is currently often develo
Externí odkaz:
https://doaj.org/article/408f7d7aa0f4479db3c92052c303678b
Autor:
Ewelina Sobierajska, Malgorzata Konopka, Anna Janaszewska, Kinga Piorecka, Andrzej Blauz, Barbara Klajnert-Maculewicz, Maciej Stanczyk, Wlodzimierz A. Stanczyk
Publikováno v:
Materials, Vol 10, Iss 5, p 559 (2017)
Polyhedral oligomeric silsesquioxane (POSS), bearing eight 3-chloroammoniumpropyl substituents, was studied as a potential nanocarrier in co-delivery systems with doxorubicin (DOX). The toxicity of doxorubicin and POSS:DOX complexes at four different
Externí odkaz:
https://doaj.org/article/706f00e6e10d4ef3a7cf0e8986d777e7
Publikováno v:
Journal of Medicinal Chemistry. 65:11415-11432
Acriflavine (ACF) has been known for years as an antibacterial drug. The identification of key oncogenic mechanisms has brought, in recent years, a significant increase in studies on ACF as a multipurpose drug that would improve the prognosis for can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76b98de487f917e48ce036010453f09
https://doi.org/10.1021/acs.jmedchem.2c00573
https://doi.org/10.1021/acs.jmedchem.2c00573
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 9264, p 9264 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
The development in the area of novel anticancer prodrugs (conjugates and complexes) has attracted growing attention from many research groups. The dangerous side effects of currently used anticancer drugs, including cisplatin and other platinum based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f1be6652be8cbdcc82444a1e631125
https://www.mdpi.com/1422-0067/22/17/9264
https://www.mdpi.com/1422-0067/22/17/9264
Publikováno v:
Molecules
Volume 26
Issue 1
Molecules, Vol 26, Iss 47, p 47 (2021)
Volume 26
Issue 1
Molecules, Vol 26, Iss 47, p 47 (2021)
Anthracyclines belong to the anticancer drugs that are widely used in chemotherapy. However, due to their systemic toxicity they also exert dangerous side effects associated mainly with cardiovascular risks. The pathway that is currently often develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5505b29d0e38265dae6ead8c155da0
Autor:
Slawomir Kazmierski, Przemyslaw Sowinski, Anna Janaszewska, Monika Marcinkowska, Barbara Klajnert-Maculewicz, Wlodzimierz A. Stanczyk, Marta Majkowska, Kinga Piorecka, Jan Kurjata, Ewa Radzikowska-Cieciura, Bartłomiej Kost
Publikováno v:
Materials
Volume 13
Issue 23
Materials, Vol 13, Iss 5512, p 5512 (2020)
Volume 13
Issue 23
Materials, Vol 13, Iss 5512, p 5512 (2020)
A novel strategy, recently developed by us, to use polyhedral oligomeric silsesquioxanes (POSS) as an anti-cancer drug carrier is presented. Anthracycline:POSS complexes were prepared by simple co-addition of doxorubicin (DOX) or daunorubicin (DAU) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dfbffcdf5c45354eda4b066c0465a1f
Autor:
Kinga Piorecka, Wlodzimierz A. Stanczyk, Irena I. Bak-Sypien, Urszula Steinke, Marek Cypryk, Jan Kurjata
Publikováno v:
RSC advances. 10(26)
This paper presents results of spectroscopic (NMR, FTIR, fluorescence), Q-TOF mass spectrometry and Z-potential analyses of interactions between octa(3-aminopropyl)silsesquioxane hydrochloride (POSS-NH2·HCl) and anticancer drug – doxorubicin hydro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9142642f502f91e910ecccfbdedd4b18
https://pubmed.ncbi.nlm.nih.gov/35495453
https://pubmed.ncbi.nlm.nih.gov/35495453
Publikováno v:
Tetrahedron Letters. 58:152-155
1 H, 1 H– 1 H COSY and 13 C NMR techniques were proven as effective methods for the analysis of functionalized doxorubicin (DOX) and daunorubicin (DAU) derivatives. These compounds represent important drug conjugate intermediates that can be couple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21a64ce3f4ff498160a422674db4bc06
https://doi.org/10.1016/j.tetlet.2016.11.118
https://doi.org/10.1016/j.tetlet.2016.11.118